| NCT Number | NCT07385651 |
| Lead Sponsor | Vanderbilt University Medical Center
Collaborators: Traferox Technology Inc. |
| Conditions | End Stage Chronic Renal Failure, Chronic Kidney Disease (Stages 4 and 5), Kidney Transplantation Recipients |
| Enrollment | 30 participants |
| Start Date | 2024-11-18 |
| Primary Completion | 2027-06-01 (estimated) |
| Study Completion | 2027-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-06 |